Prepare for your visit
Nicholas P Bell
Ophthalmology · Bellaire, TX · NPI 1831180041
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$5,547.37
in general payments reported to CMS, 2019-2025 · $332 in 2025
The $332 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Who reported paying
General payments only, top 6 by amount.
- Bausch & Lomb, A Division of Bausch Health US, LLC $2,801.07
- Abbvie INC. $925.12
- Allergan, INC. $562.52
- Alcon Vision LLC $375.05
- Rxsight INC $132.08
- Carl Zeiss Meditec USA, INC. $120.81
Drugs and devices associated with these payments
Lumigan Alphagan P Xen Glaucoma Treatment System Clareon Light Adjustable Lens (Lal) Rxsight Injector Handpiece Rxsight Injector Cartridge Rxsight Light Delivery Device (Ldd) Rxsight Contact Lens Clarus Vuity Idosetr
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Nicholas Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/264318/nicholas-p-bell